Trials / Terminated
TerminatedNCT01260870
European Study of POBA Versus Cotavance(R) Paclitaxel Coated Balloon for the Treatment of Infrapopliteal Lesions in Critical Limb Ischemia (EURO CANAL)
European Study of POBA Versus Cotavance Paclitaxel Coated Balloon for the Treatment of Infrapopliteal Lesions in Critical Limb Ischemia
- Status
- Terminated
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 44 (actual)
- Sponsor
- Bayer · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
To evaluate the procedural safety and to identify and characterize therapeutic and functional endpoint assessments in subjects with documented critical limb ischemia who received treatment with the Cotavance Paclitaxel-Coated Balloon vs. those who received POBA only.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Cotavance Paclitaxel Coated Balloon | |
| DEVICE | Standard balloon angioplasty |
Timeline
- Start date
- 2011-08-15
- Primary completion
- 2013-07-15
- Completion
- 2013-07-15
- First posted
- 2010-12-15
- Last updated
- 2024-01-30
Locations
6 sites across 4 countries: Austria, Belgium, Switzerland, United Kingdom
Source: ClinicalTrials.gov record NCT01260870. Inclusion in this directory is not an endorsement.